Cambridge Investment Research Advisors Inc. Raises Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Cambridge Investment Research Advisors Inc. lifted its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 15.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 301,910 shares of the pharmacy operator’s stock after purchasing an additional 40,095 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Walgreens Boots Alliance were worth $7,883,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Highlander Capital Management LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter valued at approximately $26,000. Venturi Wealth Management LLC raised its position in shares of Walgreens Boots Alliance by 1,241.8% during the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 981 shares during the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of Walgreens Boots Alliance by 308.4% in the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 845 shares in the last quarter. Rocky Mountain Advisers LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $30,000. Finally, Quest Partners LLC bought a new stake in Walgreens Boots Alliance in the 4th quarter valued at $30,000. 58.59% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

WBA has been the topic of several analyst reports. Leerink Partnrs reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. Bank of America cut their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research report on Tuesday, March 26th. HSBC restated a “reduce” rating and set a $20.00 target price (down previously from $27.00) on shares of Walgreens Boots Alliance in a report on Tuesday, February 20th. Truist Financial reiterated a “hold” rating and issued a $25.00 price target on shares of Walgreens Boots Alliance in a report on Monday, April 1st. Finally, SVB Leerink decreased their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a research note on Monday, March 18th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $24.36.

Check Out Our Latest Analysis on Walgreens Boots Alliance

Walgreens Boots Alliance Stock Performance

NASDAQ WBA opened at $16.03 on Tuesday. The stock has a market capitalization of $13.83 billion, a price-to-earnings ratio of -2.29, a PEG ratio of 1.00 and a beta of 0.80. The stock has a 50-day moving average of $18.37 and a 200 day moving average of $21.12. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. Walgreens Boots Alliance, Inc. has a twelve month low of $15.89 and a twelve month high of $32.89.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. During the same period in the prior year, the company posted $1.16 EPS. The business’s quarterly revenue was up 6.3% on a year-over-year basis. Sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.22 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 6.24%. Walgreens Boots Alliance’s dividend payout ratio is currently -14.29%.

Insider Buying and Selling

In other news, Director Inderpal S. Bhandari bought 3,000 shares of the firm’s stock in a transaction dated Thursday, April 11th. The shares were acquired at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari bought 3,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, April 11th. The stock was acquired at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Manmohan Mahajan purchased 6,000 shares of the stock in a transaction that occurred on Tuesday, April 2nd. The shares were acquired at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the transaction, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. Insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Stories

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.